We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact us so we can address the problem.
Advanced Glycation in macrophages induces intracellular accumulation of 7-ketocholesterol and total sterols by decreasing the expression of ABCA-1 and ABCG-1
© Iborra et al; licensee BioMed Central Ltd. 2011
- Received: 9 September 2011
- Accepted: 29 September 2011
- Published: 29 September 2011
Advanced glycation end products (AGE) alter lipid metabolism and reduce the macrophage expression of ABCA-1 and ABCG-1 which impairs the reverse cholesterol transport, a system that drives cholesterol from arterial wall macrophages to the liver, allowing its excretion into the bile and feces. Oxysterols favors lipid homeostasis in macrophages and drive the reverse cholesterol transport, although the accumulation of 7-ketocholesterol, 7alpha- hydroxycholesterol and 7beta- hydroxycholesterol is related to atherogenesis and cell death. We evaluated the effect of glycolaldehyde treatment (GAD; oxoaldehyde that induces a fast formation of intracellular AGE) in macrophages overloaded with oxidized LDL and incubated with HDL alone or HDL plus LXR agonist (T0901317) in: 1) the intracellular content of oxysterols and total sterols and 2) the contents of ABCA-1 and ABCG-1.
Total cholesterol and oxysterol subspecies were determined by gas chromatography/mass spectrometry and HDL receptors content by immunoblot.
In control macrophages (C), incubation with HDL or HDL + T0901317 reduced the intracellular content of total sterols (total cholesterol + oxysterols), cholesterol and 7-ketocholesterol, which was not observed in GAD macrophages. In all experimental conditions no changes were found in the intracellular content of other oxysterol subspecies comparing C and GAD macrophages. GAD macrophages presented a 45% reduction in ABCA-1 protein level as compared to C cells, even after the addition of HDL or HDL + T0901317. The content of ABCG-1 was 36.6% reduced in GAD macrophages in the presence of HDL as compared to C macrophages.
In macrophages overloaded with oxidized LDL, glycolaldehyde treatment reduces the HDL-mediated cholesterol and 7-ketocholesterol efflux which is ascribed to the reduction in ABCA-1 and ABCG-1 protein level. This may contribute to atherosclerosis in diabetes mellitus.
- advanced glycation
- diabetes mellitus
- 7-ketocholesterol; ABCA-1
Oxysterols are oxidized derivatives of cholesterol that act as important mediators of lipid metabolism, particularly by driving intracellular lipid homeostasis and the reverse cholesterol transport [1, 2]. Nonetheless, the accumulation of 7-ketocholesterol, 7alpha-hydroxycholesterol and 7beta-hydroxycholesterol has been implicated in the development of atherosclerosis as wells as inflammation and macrophage foam cell death .
In diabetes mellitus, advanced glycation end products (AGE) impair lipid metabolism and reverse cholesterol transport by diminishing the expression of ABCA-1, ABCG-1 and the activity of lecithin cholesterol acyltransferase [4–6]. On the hand, glycation enhances cholesteryl ester transfer protein activity making more cholesterol available for arterial wall macrophage by the uptake of modified LDL by scavenger receptors . There are no data available on the role played by intracellular advanced glycation elicited by the treatment with oxoaldehydes - that induce a rapid formation of AGE - in the intracellular content of oxysterols subspecies. Then the aim of this study was to analyze in oxidized LDL-overloaded macrophages treated with HDL alone or HDL plus LXR agonist (T0901317) the effect of advanced glycation in the selective distribution of oxysterols and the total content of sterols as well as the expression of ABCA-1 and ABGC-1.
Lipoprotein isolation and oxidative modification
Low density lipoprotein (LDL; d = 1.019-1.063 g/mL) and high density lipoprotein (HDL; d = 1.063-1.121 g/mL) were isolated after sequential preparative ultracentrifugation of fresh plasma drawn from healthy donors and were purified by discontinuous gradient ultracentrifugation. After dialysis, all lipoproteins fractions were sterilized in a 0.22 μm filter. LDL was oxidized according to Steinbrecher et al.  and protein was measured by the Lowry technique 
Cell Culture and Experimental Protocol
J774 macrophages were cultured in RPMI 1640 medium (Gibco, Grand Island, New York, USA) containing 10% fetal calf serum (Cultilab, Campinas, Brazil), penicillin and streptomycin (Gibco), and maintained in a 5% CO2 incubator at 37°C. After reaching confluence, macrophages were enriched with oxidized LDL (50 μg/mL of low glucose DMEM - Gibco) for 48h and then treated with 0.5 mM glycolaldehyde (Sigma Chem. Com. St. Louis, USA) (GAD-macrophages) or DMEM alone (C-macrophages) for the last 5h, in the absence or presence of the LXR-agonist, T0901317 (1 μM). Cells were carefully washed and incubated with 50 μg/mL of HDL (5 h) in the absence or presence of T0901317.
Oxysterols and total cholesterol determination
Sterol standards (cholesterol, 7alpha-hydroxycholesterol, 7beta-hydroxycholesterol, 7-ketocholesterol, colestan-3beta, 5alpha, 6beta-triol, 5alpha, 6alpha-epoxycholesterol, 5beta, 6beta-epoxycholesterol, 24(s), 25 epoxycholesterol, 25-hydroxycholesterol and 27-hydroxycholesterol), including internal standard 5beta-cholestane, were obtained from Steraloids Inc. (Wilton, NH, USA).
Cellular lipids were extracted with hexane:isopropanol (3:2, v/v). To the lipid extract it was added 10 μg of 5alpha-cholestane (internal standard) following evaporation under nitrogen. Samples were redissolved in 1.0 mL toluene/ethyl acetate (1 : 1, v/v) and applied to diol extraction columns (Waters Corporation, Ireland), previously conditioned with the same solvent. After collection of the first eluent fraction under mild vacuum, columns were eluted with 2.0 mL of toluene/ethyl acetate and the eluent was pooled with the original fraction. The toluene/ethyl acetate fraction was evaporated to dryness under nitrogen, and redissolved in 2.0 mL diethyl ether and subjected to a two-phase alkaline saponification procedure. The recovered ether phase was dryness under nitrogen and derivatized after additions of 100 μL pyridine (Merck, Rio de Janeiro, Brazil) and N,O-bis(trimethylsylil) trifluoroacetamide (BSTFA; Supelco - Bellefonte, USA). Vials were sealed, purged with nitrogen, and heated to 60°C for 60 min . Samples were transferred to tubes with ether, followed by gas chromatography-Mass Spectrometer detection (GC-MS) analysis. One μL aliquot was then injected into a QP 2010 plus (Shimadzu - Kyoto, Japan) gas chromatograph equipped with Rxi-1ms de 30 m (Restec - Bellefonte, EUA) and Mass Spectrometer detector. Helium was used as the carrier gas at a flow rate of 5 mL/min; the injection temperature was set at 290°C and the initial column temperature at 240°C, with a split ratio of 1:5. The ion detector temperature was set at 300°C and a programmed temperature run was used with the initial temperature held for 1 min followed by a 5°C/min temperature ramp to 290°C, with the final temperature held for 20 min .
J774 Macrophages were scraped into Tris buffer saline containing protease inhibitors. Equal amounts of cell protein were applied to a 6% polyacrylamide gel (SDS-PAGE) and blotted to Amersham Hybond ECL Nitrocellulose Membrane (GE healthcare, Little Chalfont, UK). The blots were treated with defatted dry milk (5%) in PBS/0.05% Tween 20, and incubated for 3h with primary antibodies, anti ABCA-1 or anti ABCG-1, 1:1000 (Novus Biologicals, Inc., Littleton, USA) in blocking buffer. After washing three times with TBS/0.05% Tween 20, membranes were incubated with peroxidase-conjugated anti-mouse or anti-rabbit antibodies (GE healthcare) for 2 h, washed and developed with a SuperSignal West Pico Chemiluminescent Substrate (Termo Scientific Rockford, IL, EUA). Chemiluminescence was detected by ImageQuant 350 (GE Healthcare, Piscata Way, NJ, USA). Data are presented as arbitrary units corrected per beta-actin 1: 1000 (Fitzgerald industries int., Acton, MA, USA).
Statistical analyses were performed using GraphPad Prism 4.0 software (GraphPad Prism, Inc., San Diego, CA). Student's T test was utilized to compare results (mean ± SD). One way ANOVA and Bonferroni post test (mean ± SD) was utilized to compare results among groups. A p-value < 0.05 was considered statistically significant.
Oxysterols and total cholesterol in oxidized LDL and native HDL (ng/μg of protein ± DP)
(n = 5)
(n = 2)
73.1 ± 18
0.96 ± 0.70
38.1 ± 8
0.64 ± 0.13
36.6 ± 8
0.38 ± 0.11
cholesterol- 5,6 α
16.16 ± 4
0.17 ± 0.04
12.97 ± 11
0.01 ± 0.02
1.321 ± 0.3
0.19 ± 0.01
1.90 ± 0.22
1.06 ± 0.2
0.03 ± 0.01
0.11 ± 0.07
0.02 ± 0.01
179.4 ± 39
5.83 ± 2.79
99.1 ± 7
93.73 ± 0.89
Oxysterols and total cholesterol in control (C) and glycolaldehyde-treated macrophages (GAD)
86.7 ± 16
72.8 ± 14*
68.4 ± 14*
83.8 ± 19
74.2 ± 13
79.8 ± 19
26.7 ± 9
20.4 ± 6
21.5 ± 10
25.5 ± 10
23.6 ± 6
22.8 ± 10
9.2 ± 4
8.1 ± 3
8.1 ± 5
9.4 ± 3
8.8 ± 2
8.6 ± 4
22.6 ± 9
20 ± 5
16.9 ± 6
24.2 ± 6
22.9 ± 6
20.5 ± 6
cholesterol- 5,6 α
7.1 ± 2
6.6 ± 2
5.5 ± 2
7.4 ± 2
6.2 ± 2
6.7 ± 3
3.8 ± 2
3.5 ± 2
2.8 ± 1
3.9 ± 2
3.7 ± 2
3.5 ± 2
0.48 ± 0.2
0.51 ± 0.3
0.44 ± 0.2
0.55 ± 0.3
0.52 ± 0.2
0.48 ± 0.2
0.35 ± 0.3
0.38 ± 0.1
0.42 ± 0.2
0.43 ± 0.2
0.37 ± 0.1
0.40 ± 0.2
10 ± 3
8.3 ± 2
8.5 ± 5
10.5 ± 4
9.4 ± 3
9.2 ± 3
244 ± 57
203 ± 47*
191 ± 44*
227 ± 52
214 ± 53
224 ± 50
As compared to oxidized LDL non-overloaded cells, in GAD-macrophages, oxidized LDL enrichment did not change cell content of ABCG-1. In this case, the presence of HDL diminished 36.6% the amount of ABCG-1 in comparison to control cells treated with this lipoprotein. Also, in GAD-macrophages the incubation with HDL and HDL + T0901317 reduced the protein level of ABCG-1 as compared to GAD-cells maintained in culture medium alone (Figure 5).
Advanced glycation end products are independently associated with the development of atherosclerosis . Oxysterols, mainly 24(s),25 epoxycholesterol, 22(R)-hydroxycholesterol, o 24(S)-hydroxycholesterol and 25 hydroxycholesterol , modulate intracellular cholesterol exportation by increasing the LXR-mediated expression of ABCA-1 and ABCG-1 . On the other hand, 7-oxygenated cholesterol derivatives such as 7-ketocholesterol, are related to cell toxicity and death by inducing inflammation and endoplasmic reticulum stress . In fact, these oxysterols are prevalent in oxidized LDL and its accumulation in arterial wall macrophages is a hallmark of atherosclerosis and plaque instability [15, 16].
Oxidized LDL utilized to overload macrophages with lipids previously to the incubation with HDL and LXR agonist was in fact enriched in 7-ketocholesterol  due to the no enzymatic conversion of cholesterol into oxysterols. HDL on its turn presented very small amounts of oxysterols maybe related to the acquisition of these components from other lipoproteins before plasma ultracentrifugation .
In cells grown in the absence of oxidized LDL only a very small amount of oxysterols was detected by CG/MS in regard to the total amount of cell cholesterol (data not shown). Then, the majority of oxysterols that we found in oxidized LDL-overloaded macrophages was originated from the uptake of the modified LDL.
We found that advanced glycation in macrophages induced by the treatment with glycolaldehyde disturbs the exportation of 7-ketocholesterol, inducing its intracellular accumulation. Interestingly, GAD treatment mitigates the HDL ability to remove cell cholesterol and 7-ketocholesterol even in the presence of T0901317. In cholesterol-enriched macrophages, ABCA-1 contributes to a large amount of cholesterol net efflux to lipid-poor apolipoprotein A-I generating pre- betaHDL. In this present study a reduced amount of cellular ABCA-1 protein level was observed in GAD-macrophages with a small increment in its expression even after LXR agonist treatment.
We have recently demonstrated that advanced glycated albumin isolated from poorly controlled diabetes mellitus' serum reduces protein content of ABCA-1 and ABCG-1 in macrophages, impairing cholesterol efflux and inducing intracellular lipid accumulation . It has been previously shown that advanced glycation reduces ABCG-1 mRNA levels by impairing ABCG-1 gene transcriptional activity independently of LXR . On the other hand, advanced glycation induced both by oxoaldehyde or advanced glycated albumin treatment reduces ABCA-1 protein levels in macrophages which are not related to alterations in ABCA-1 mRNA levels [6, 20]. The mechanisms that regulate ABCA-1 final protein content in cells submitted to advanced glycation are not completely understood so far but may involve post-translational modifications of ABCA-1. Previous data from our group showed that advanced glycated albumin induces the expression of endoplasmic reticulum stress and unfolded protein response markers in macrophages. Interestingly, a chemical chaperone (4-phenylbutyric acid) that alleviates endoplasmic reticulum stress is able to recover ABCA-1 level and apo A-I- mediated cholesterol efflux in these cells . These events were also related to the elevated generation of reactive oxygen species in glycolaldehyde-modified albumin-treated macrophages, since treatment with aminoguanidine that reduced ROS generation was able to restore ABCA-1 protein content . AGE-albumin also primers macrophages to inflammation which is related to the diminished cholesterol exportation to apolipoprotein A-I . Although we were not able to detect by immunoblot CML derivatives in ABCA-1 and ABCG-1, at this point we cannot completely exclude that part of the changes observed in the content and activity of ABCA-1 and ABCG-1 relates to GAD modification of both transporters.
Oxidative stress and inflammation induced by AGE trigger endoplasmic reticulum stress that is also observed in instable atherosclerotic plaques enriched in 7-ketocholesterol. More recently, Yehuda et al  have demonstrated that a lipid extract obtained from carotid atherosclerotic lesion induces the expression of inflammatory markers in macrophages, which was mainly attributed to the cholesterol and oxysterol-enriched fraction (7alpha-hydroxycholesterol, 7beta-hydroxycholesterol, 7-ketocholesterol and 26-hydroxycholesterol) of the lipid extract.
ABCG-1 plays a major role in the efflux of 7-ketocholesterol to large HDL minimizing its apoptotic effects in macrophages. Nonetheless, in ABCG-1 knockout mice the development of atherosclerosis is still controversial. It is possible that in those animal models the compensatory expression of ABCA-1 may abrogates the absence of ABCG-1-mediated lipid efflux. In the setting of hyperglycemia, AGE formation is prevalent compromising both the expressions of ABCA-1 and ABCG-1. Then, the accumulation of 7-ketocholesterol together with total sterols may aggravate the development of atherosclerosis in diabetes mellitus.
This work was supported by a grant from Fundação de Amparo à Pesquisa do Estado de Sao Paulo (FAPESP) to M Passarelli (#2009/53869-9). RT Iborra (#2007/59710-6), A Machado-Lima (#2006/55496-7), and G Castilho (#10/50108-4) were supported by fellowships from FAPESP. The authors are grateful to Fundação Faculdade de Medicina and Laboratorios de Investigação Medica for their continuous support.
- Björkhem I: Do oxysterols control cholesterol homeostasis?. J Clin Invest. 2002, 110 (6): 725-30.PubMed CentralView ArticlePubMedGoogle Scholar
- Schroepfer GJ: Oxysterols: modulators of cholesterol metabolism and other processes. Physiological Reviews. 2000, 80 (1): 361-554.PubMedGoogle Scholar
- Berthier A, Lemaire-Ewing S, Prunet C, Montange T, Vejux A, Pais de Barros JP, Monier S, Gambert P, Lizard G, Néel D: 7-Ketocholesterol-induced apoptosis. Involvement of several pro-apoptotic but also anti-apoptotic calcium-dependent transduction pathways. Febs J. 2005, 272 (12): 3093- 10.1111/j.1742-4658.2005.04723.xView ArticlePubMedGoogle Scholar
- Machado AP, Pinto RS, Moysés ZP, Nakandakare ER, Quintão EC, Passarelli : Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products. M Int J Biochem Cell Biol. 2006, 38 (3): 392-10.1016/j.biocel.2005.09.016.View ArticleGoogle Scholar
- Matsuki K, Tamasawa N, Yamashita M, Tanabe J, Murakami H, Matsui J, Imaizumi T, Satoh K, Suda T: Metformin restores impaired HDL-mediated cholesterol efflux due to glycation. Atherosclerosis. 2009, 206 (2): 434- 10.1016/j.atherosclerosis.2009.03.003View ArticlePubMedGoogle Scholar
- Isoda K, Folco EJ, Shimizu K, Libby P: AGE-BSA decreases ABCG1 expression and reduces macrophage cholesterol efflux to HDL. Atherosclerosis. 2007, 192 (2): 298- 10.1016/j.atherosclerosis.2006.07.023View ArticlePubMedGoogle Scholar
- Passarelli M, Catanozi S, Nakandakare ER, Rocha JC, Morton RE, Shimabukuro AF, Quintão EC: Plasma lipoproteins from patients with poorly controlled diabetes mellitus and "in vitro" glycation of lipoproteins enhance the transfer rate of cholesteryl ester from HDL to apo-B-containing lipoproteins. Diabetologia. 1997, 40 (9): 1085-93. 10.1007/s001250050791View ArticlePubMedGoogle Scholar
- Steinbrecher UP, Witztum JL, Parthasarathy S, Steinberg D: Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis. 1987, 7 (2): 135- 10.1161/01.ATV.7.2.135View ArticlePubMedGoogle Scholar
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem. 1951, 193 (1): 265-75.PubMedGoogle Scholar
- Ferderbar S, Pereira EC, Apolinário E, Bertolami MC, Faludi A, Monte O, Calliari LE, Sales JE, Gagliardi AR, Xavier HT, Abdalla DS: Cholesterol oxides as biomarkers of oxidative stress in type 1 and type 2 diabetes mellitus. Diabetes Metab Res Rev. 2007, 23 (1): 35- 10.1002/dmrr.645View ArticlePubMedGoogle Scholar
- Peppa M, Raptis SA: Advanced glycation end products and cardiovascular disease. Curr Diabetes Rev. 2008, 4 (2): 92- 10.2174/157339908784220732View ArticlePubMedGoogle Scholar
- Shibata N, Glass CK: Macrophages, Oxysterols and Atherosclerosis. Circ J. 2010, 74 (10): 2045-51. 10.1253/circj.CJ-10-0860View ArticlePubMedGoogle Scholar
- Adorni MP, Zimetti F, Billheimer JT, Wang N, Rader DJ, Phillips MC, Rothblat GH: The roles of different pathways in the release of cholesterol from macrophages. J Lipid Res. 2007, 48 (11): 2453-62. 10.1194/jlr.M700274-JLR200View ArticlePubMedGoogle Scholar
- Castilho G, Philipson PB, Pinto RS, Nakandakare ER, Quintão ECR, Passarelli M: Glycoxidation reduces cholesterol biosynthesis and increases cholesterol esterification in J-774 macrophages. Diabetes. 2007, 56 (suppl 1): 728-P.Google Scholar
- Kritharides L, Jessup W, Mander EL, Dean RT: Apolipoprotein A-I-mediated efflux of sterols from oxidized LDL-loaded macrophage. Arterioscler Thromb Vasc Biol. 1995, 15: 276- 10.1161/01.ATV.15.2.276View ArticlePubMedGoogle Scholar
- Gelissen IC, Brown AJ, Mander EL, Kritharides L, Dean RT, Jessup W: Sterol efflux is impaired from macrophage foam cells selectively enriched with 7-ketocholesterol. J Biol Chem. 1996, 271 (30): 17852- 10.1074/jbc.271.30.17852View ArticlePubMedGoogle Scholar
- Jessup W, Kritharides L: Metabolism of oxidized LDL by macrophages. Curr Opin Lipidol. 2000, 11 (5): 473-81. 10.1097/00041433-200010000-00005View ArticlePubMedGoogle Scholar
- Lin CY, Morel DW: Esterification of oxysterols in human serum: effects on distribution and cellular uptake. J Lipid Res. 1996, 37 (1): 168-78.PubMedGoogle Scholar
- Machado-Lima A, Iborra RT, Pinto RS, Sartori CH, Oliveira ER, Stefano JT, Nakandakare ER, Giannella-Neto D, Corrêa-Giannella L, Passarelli M: AGE-albumin induces intracellular lipid accumulation by modifying the expression of genes involved in macrophage reverse cholesterol transport and cholesterol homeostasis. Atherosclerosis. 2011, 12 (suppl 1): 35-36-P.View ArticleGoogle Scholar
- Passarelli M, Tang C, McDonald TO, O'Brien KD, Gerrity RG, Heinecke JW, Oram JF: Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal from cells. Diabetes. 2005, 54 (7): 2198- 10.2337/diabetes.54.7.2198View ArticlePubMedGoogle Scholar
- Pinto RS, Paim BA, Vercesi AE, Castilho G, Nakandakare ER, Quintão EC, Passarelli M: The reduction in hdl receptor levels in macrophages is related to ros generation induced by advanced glycated albumin. Atherosclerosys. 2011, 12 (suppl 1): 35-P.View ArticleGoogle Scholar
- Valencia JV, Mone M, Koehne C, Rediske J, Hughes TE: Binding of receptor for advanced glycation end products (RAGE) ligants is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products. Diabetologia. 2004, 47 (5): 844- 10.1007/s00125-004-1392-9View ArticlePubMedGoogle Scholar
- Yehuda H, Szuchman-Sapir A, Khatib S, Musa R, Tamir S: Human atherosclerotic plaque lipid extract promotes expression of proinflammatory factors in human monocytes and macrophage-like cells. Atherosclerosis. .Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.